Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Abstract |
|
Authors | Radek Pudil, Christian Mueller, Jelena Čelutkienė, Peter A Henriksen, Dan Lenihan, Susan Dent, Ana Barac, Susanna Stanway, Javid Moslehi, Thomas M Suter, Bonnie Ky, Martin Štěrba, Daniela Cardinale, Alain Cohen-Solal, Carlo Gabriele Tocchetti, Dimitrios Farmakis, Jutta Bergler-Klein, Markus S Anker, Stephan Von Haehling, Yury Belenkov, Zaza Iakobishvili, Christoph Maack, Fortunato Ciardiello, Frank Ruschitzka, Andrew J S Coats, Petar Seferovic, Mitja Lainscak, Massimo F Piepoli, Ovidiu Chioncel, Jereon Bax, Jean-Sebastien Hulot, Hadi Skouri, Eva Simona Hägler-Laube, Riccardo Asteggiano, Teresa Lopez Fernandez, Rudolf A de Boer, Alexander R Lyon |
Journal | European journal of heart failure
(Eur J Heart Fail)
Vol. 22
Issue 11
Pg. 1966-1983
(11 2020)
ISSN: 1879-0844 [Electronic] England |
PMID | 33006257
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 European Society of Cardiology. |
Chemical References |
- Antineoplastic Agents
- Biomarkers, Tumor
- Cardiotonic Agents
|
Topics |
- Antineoplastic Agents
(administration & dosage, adverse effects)
- Biomarkers, Tumor
(blood)
- Cardiotonic Agents
(administration & dosage)
- Cardiotoxicity
(blood, diagnosis, etiology)
- Heart Failure
(blood, chemically induced, diagnosis)
- Humans
- Neoplasms
(blood, drug therapy)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|